Three Arch Partners

edit

Three Arch Partners was formed in 1993 to provide young companies with access to relevant clinical and business resources, as well as capital. Three Arch has helped create, build and fund more than 100 important new healthcare companies. These companies have often become the clinical and market leaders in their respective fields, and have generated strong returns. The fund focuses on opportunities in medical devices and healthcare services, and less frequently in biotechnology.

Milestones

edit

Investments

Videos

Sources

1. Neuronetics, Inc.: Series D $30M (onbiovc.com) [edit]
2. Calistoga Pharmaceuticals, Inc.: Series B $30M (onbiovc.com) [edit]
3. Visiogen, Inc.: Series D $40M (onbiovc.com) [edit]
4. iScience Interventional, Inc.: Series F $20.5M (onbiovc.com) [edit]
5. Capital Report Index [edit]
6. VentureBeat (venturebeat.com) [edit]
7. Cardiac Concepts Raises $21 Million (equityhelpdesk.com) [edit]
8. APT Pharmaceuticals Secures $32 Million in Series B Financing (aptbio.com) [edit]
9. Novasys Medical takes $49.5M for women’s medical device (deals.venturebeat.com) [edit]
10. Capital Funding Report [edit]
11. Defibrillator maker Cameron Health takes in $14M (deals.venturebeat.com) [edit]
12. Benvenue Medical Closes $15 Million Series B Financing (benvenuemedical.com) [edit]
13. TriReme Medical Inc. Announces $15.5 Million Series C Financing (trirememedical.com) [edit]
14. Satiety pulls in $30M for obesity device (venturebeat.com) [edit]
15. Reliant Technologies raises $15M for aesthetic laser and surgery products (deals.venturebeat.com) [edit]
16. Sirtris Pharmaceuticals closes $27M second round (boston.bizjournals.com) [edit]
17. Free & Clear banks on healthy savings (seattletimes.nwsource.com) [edit]